Table: Jcr Pharmaceuticals - 6-MTH group results

JCR Pharmaceuticals

25/10/2023 08:00

Oct 25 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               24.27               15.58            45.40    
                   (+55.8 pct)         (-45.1 pct)      (+32.2 pct) 
  Operating            6.90              744 mln           10.50    
                  (+826.2 pct)         (-94.5 pct)     (+111.0 pct) 
  Recurring            7.13                1.57            10.00    
                  (+353.9 pct)         (-88.6 pct)      (+84.6 pct) 
  Net                  5.25              962 mln            7.30    
                  (+445.6 pct)         (-89.6 pct)      (+93.5 pct) 
  EPS               42.10 yen           7.77 yen         58.71 yen  
  EPS Diluted       41.90 yen           7.74 yen                    
  Ann Div                               20.00 yen        20.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T